An expert discusses how multidisciplinary collaboration can be enhanced through shared knowledge of available drugs and biomarkers among oncologists and pathologists, standardized interpretation ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. The ...

Ovarian cancer is often detected at a late stage, providing poor prognoses, while benign ovarian growths can lead to unnecessary surgeries. A new combined fragmentomic–protein biomarkers test could ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...

Researchers have discovered a way that ovarian cancer tumors manipulate their environment to resist immunotherapy and identified a drug target that could overcome that resistance. The study used a ...

Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.

Researchers have discovered a mechanism that ovarian tumors use to cripple immune cells and impede their attack -- blocking the energy supply T cells depend on. The work points toward a promising new ...

Perturb-map spatial genomics reveals the genes helping tumors grow and resist immunotherapy. The left image shows ovarian tumors in mice tissue, while the right image, enhanced by advanced technology, ...